Featured News

 

Latest News

Enamine, EMBL Partner on Cancer Drug Discovery Research
Enamine, EMBL Partner on Cancer Drug Discovery Research
News   Apr 25, 2017

A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house.

READ MORE

A Genetic Scalpel for Modifying the Bacteria in Your Gut
A Genetic Scalpel for Modifying the Bacteria in Your Gut
News   Apr 24, 2017

Yale University researchers have developed new methods for regulating gene activity in a widespread group of microbiome bacteria in the gut of living mice.

READ MORE

Reversing Gene Damage to Treat Blindness
Reversing Gene Damage to Treat Blindness
News   Apr 24, 2017

n mouse models, advanced gene editing tool reprogrammed photoreceptor rods to mutation-resistant cones.

READ MORE

Diet Therapy Could Be Effective at Starving Cancer
Diet Therapy Could Be Effective at Starving Cancer
News   Apr 24, 2017

Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival, according to new research published in Nature.

READ MORE

A Promising Model for a Devastating Genetic Deficiency
A Promising Model for a Devastating Genetic Deficiency
News   Apr 24, 2017

Study describes how a complete knockout of the Ngly1 gene in mice leads to death just before birth, which can be partially rescued by the second knockout of another gene called Engase.

READ MORE

Metrion and Venomtech Collaborate
Metrion and Venomtech Collaborate
News   Apr 24, 2017

Combining Metrion's electrophysiological expertise and screening capability with Venomtech's compound library and venom-based drug discovery expertise will rapidly exploit and develop novel tools for ion channel drug discovery research.

READ MORE

Malaria Parasite Protein Shows Promise as Cancer Therapeutic
Malaria Parasite Protein Shows Promise as Cancer Therapeutic
News   Apr 21, 2017

A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

READ MORE

FDA Approves Pembrolizumab for Hodgkin Lymphoma
FDA Approves Pembrolizumab for Hodgkin Lymphoma
News   Apr 20, 2017

On March 14, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda®) for the treatment of some patients with classical Hodgkin lymphoma (cHL).

READ MORE

The Next Generation of Pancreatic Cancer Therapeutics
The Next Generation of Pancreatic Cancer Therapeutics
News   Apr 20, 2017

Currently, there are not many effective therapies available other than surgery, and that is not an option for many patients.

READ MORE

Individualizing Health Care One Byte at a Time
Individualizing Health Care One Byte at a Time
News   Apr 20, 2017

A framework called PhenomeNET finds disease genes in a patient-specific manner by matching a patient's phenotype (symptoms) to a large database of gene-to-phenotype associations, including those from non-human model organisms.

READ MORE